A study published by David Cheng, Postdoctoral Scientist, Neuroscience Research, University of New South Wales, NSW, Australia, says that CBD has a potential as a preventive measure against symptoms of Alzheimer’s. This presents yet another exciting development for medical researchers, given the persistent challenges to finding effective solutions for this condition.
Other targets for CBD include transient receptor potential (TRP) channels that are involved with the modulation of intracellular calcium (1, 6). Cannabinoids are highly lipophilic, allowing access to intracellular sites of action, resulting in increases in calcium in a variety of cell types including hippocampal neurons. CBD actions on calcium homeostasis may provide a basis for CBD neuroprotective properties.
The statements made regarding these products have not been evaluated by the Food and Drug Administration. The efficacy of these products has not been confirmed by FDA-approved research. These products are not intended to diagnose, treat, cure or prevent any disease. All information presented here is not meant as a substitute for or alternative to information from health care practitioners. Please consult your health care professional about potential interactions or other possible complications before using any product.
At this time, there does seem to be a growing body of basic pharmacologic data suggesting there may be a role for CBD, especially in the treatment of refractory epilepsy. However, given the lack of well-controlled trials, we must also ask if we are getting ahead of ourselves. Clearly, this is an emotionally and politically charged issue. If this were any other uninvestigated pharmaceutical compound, would we feel as compelled to make the agent widely available before statistically valid class 1 evidence was available for review? Until data from well-designed clinical trials are available and reliable, and standardized CBD products that are produced using GMP are available, caution must be exercised in any consideration of using CBD for the treatment of epilepsy. In the meantime, based upon promising preliminary data, further clinical research should be wholeheartedly pursued.
As mentioned above, CBDPure is a natural oil extracted through cold pressing and CO2 procedures from Cannabis sativa. Specialists have identified over 80 compounds known as cannabinoids. Their research so far showed that CBD is the predominant cannabinoid, accounting for over 40% of the cannabinoids concentration. It is also the most beneficial for human health, at least from the cannabinoids studied so far.
Generalized pain, for instance, has dozens upon dozens of high profile research and clinical studies that have been carried out in universities and laboratories around the globe. One of the most well-publicized of these studies took place back in 2008, in which results determined that “cannabinoid analgesics (pain relievers) have generally been well tolerated in clinical trials … with acceptable adverse event profiles (meaning acceptable effectiveness for practical use).

If you’re ready to get your CBD on, picking any of these high-quality vape liquids will give you the best possible introduction to this wildly popular substance. The VaporVanity editorial team has verified that these are some of the best CBD vape oils on the market today, so you can rest easy knowing that as long as you choose from this list, any choice you make is certain to be a good one.

Although several clinical studies focused on the health effects of CBD, the results available so far were not enough to convince the FDA to approve it as a drug. The FDA does not agree with its use as a dietary supplement either, but as long as sellers publish the appropriate disclaimers (like those on the CBDPure website and labels), it’s not up to them.
According to the largest study to date, researchers reported that after treating 162 patients with an extract of 99% cannabidiol (CBD), for a 12 week period. the intervention reduced motor seizures at a rate similar to existing drugs ( a median of 36.5 percent) and 2% of patients became completely seizure free. Other studies have shown that it can act as an anticonvulsant.
Also listed among our low potency products is our bestselling CanChew® gum. With just 10 mg of CBD per piece of gum, it is easy to get started with CBD as a supplement, and adding more CBD to your diet is as simple as chewing another piece of gum. Another approachable product for those just starting out with CBD, CanChew® gum is a simple delivery method for getting your daily CBD.
To make matters more confusing, nine states (including California, Washington, and Colorado) let residents buy cannabis-based products with or without THC. Nearly two dozen other “medical marijuana states” allow the sale of cannabis, including capsules, tinctures, and other items containing CBD or THC, at licensed dispensaries to people whose doctors have certified that they have an approved condition (the list varies by state but includes chronic pain, PTSD, cancer, autism, Crohn’s disease, and multiple sclerosis). Sixteen more states legalized CBD for certain diseases.
The information on this website has not been evaluated by the Food & Drug Administration or any other medical body. We do not aim to diagnose, treat, cure or prevent any illness or disease. Information is shared for educational purposes only. You must consult your doctor before acting on any content on this website, especially if you are pregnant, nursing, taking medication, or have a medical condition.
Ranging from irritating to debilitating, joint pain can be tricky to treat. If your pain is mild, ibuprofen or acetaminophen might be adequate. But the worse it gets, the more likely you are to be prescribed antidepressants, muscle relaxants, or even opioids. Because of the side effects associated with these prescription medications, there has been quite a bit of research on CBD and joint pain — with promising results. Here are a few studies that point to CBD’s potential:

Studies have demonstrated that CBD has a low affinity for the CB1 receptors, but even at low concentrations, CBD decreases G-protein activity (3). CB1 receptors are expressed on many glutamatergic synapses that have been implicated in seizure threshold modulation. CBD may act at CB1 receptors to inhibit glutamate release (4). Studies have shown changes in the expression of CB1 receptors during epileptogenesis and after recurrent seizures (5). CB1 receptor expression is upregulated at GABAergic synapses and shown to be downregulated at glutamatergic synapses in epilepsy, contributing to lowering seizure thresholds.
I stopped by Moon Juice after work, feeling a little nervous and excited all at once. “You might notice that your body feels a bit heavy after you try it—sometimes when I take it I feel like I just want to sit down and chill,” said the women behind the Moon Juice counter who helped me. Prepped for potential side effects, I emptied one dropper’s worth of CBD oil into my chamomile tea as soon as I got home … And didn’t feel anything. A few hours later I got into bed and immediately fell asleep.

Generalized pain, for instance, has dozens upon dozens of high profile research and clinical studies that have been carried out in universities and laboratories around the globe. One of the most well-publicized of these studies took place back in 2008, in which results determined that “cannabinoid analgesics (pain relievers) have generally been well tolerated in clinical trials … with acceptable adverse event profiles (meaning acceptable effectiveness for practical use).
The information on this website has not been evaluated by the Food & Drug Administration or any other medical body. We do not aim to diagnose, treat, cure or prevent any illness or disease. Information is shared for educational purposes only. You must consult your doctor before acting on any content on this website, especially if you are pregnant, nursing, taking medication, or have a medical condition.
A survey of patients seen in a tertiary epilepsy center found that 21% of patients admitted to using marijuana in the last year, and 24% of patients believed marijuana to be effective for their seizures (10). While interesting, this anecdotal observation does not rise to the level of evidence needed to evaluate a potential new therapeutic modality.
The endocannabinoid system is spread throughout your brain and body, but primarily throughout your central nervous system. The interaction between cannabinoids and receptors is what produces effects like the regulation of mood, pain, appetite, inflammation, and memory. Plant-based cannabinoids, found in cannabis plants, also interact with the receptors (whimsically named CB1 and CB2) in the endocannabinoid system, and each affects your body in different ways. CBD and its infamous cousin THC are the 2 most well-known cannabinoids.
But CBD has recently become a major player in the world of athletics for two reasons. First, it has proven anti-inflammatory properties. This has been pretty firmly established through a number of studies. For example, in a 2009 lab study, researchers found that CBD significantly suppressed chronic inflammatory pain by activating glycine receptors at the spinal level. CBD is also a known analgesic, meaning it has pain-relieving properties. Many athletes use CBD after intense workouts to help manage pain from aching muscles and joints. And recently, the World Anti-Doping Agency removed CBD from its list of banned substances, opening the door for professional athletes to make use of the extract for pain relief.

As the CBD oil market continues to grow, more and more products are being sold online or in your local health food stores. You can find many types of CBD and each one is used in a different way. The most common forms of CBD available include the following. (Of course, you should always consult your healthcare professional prior to using CBD and read and follow all label directions.)


It’s safe to say that Charlotte’s Web is probably the most recognized CBD brand out there — and it’s not all hype. This company pioneered the CBD industry and made it their mission to de-stigmatize CBD by setting the bar high for transparency. They produce and oversee their organic CBD products from seed to sale, standing behind them with a solid return policy. 
×